A study analysing clinical features patients treated with cMET-targeted therapy and consequent resistance mechanisms in advanced non-squamous NSCLC with METex14del
Latest Information Update: 23 Apr 2021
At a glance
- Drugs Crizotinib (Primary)
- Indications Non-small cell lung cancer
- Focus Pharmacodynamics; Therapeutic Use
- 23 Apr 2021 New trial record